Vote Scores

Home / Companies / Nuvation Bio Inc. / 21 May 2026

Meeting · year to 30 June 2026275 filers reporting

Nuvation Bio Inc.: meeting of 21 May 2026

Votes reported on Form N-PX, item by item

275 Form N-PX filers reported votes at the Nuvation Bio Inc. meeting of 21 May 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 53.7% of reported votes for; 60 filers withheld from or voted against at least one nominee.

367 vote records from 93 filers. 32 of the 93 filers that marked the item either way voted against management.

39.8% for0.0% against60.2% other34.4% against management93 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

411 vote records from 275 filers. 26 of the 262 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

85.8% for9.1% against5.1% other9.9% against management275 filers97.1% for2.9% against0.0% other2.9% against management208,132,111 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

183 vote records from 93 filers. 0 of the 92 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

98.9% for0.0% against1.1% other0.0% against management93 filers100.0% for0.0% against0.0% other0.0% against management61,522,225 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
Franklin TempletonNo reportForNo report
InvescoForAgainst *For
EquitableForForFor
Charles SchwabSplit or no voteForFor
Nuveen and TIAAAbstain or withhold *ForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeAbstain or withhold *ForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialNo reportForNo report
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesSplit or no voteForFor
SEISplit or no voteForFor
T. Rowe PriceForForFor
Lincoln FinancialAbstain or withholdForFor
VoyaAbstain or withhold *ForFor
Russell InvestmentsSplit or no voteForFor
NationwideForForFor
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsForForFor
Guggenheim and RydexAbstain or withhold *ForFor
BNY MellonAbstain or withhold *ForFor
PrincipalAbstain or withhold *ForFor
Pacific Life fundsForForFor
Global XSplit or no voteForFor
AllianceBernsteinNo reportForNo report
DWSAbstain or withhold *ForFor
AllspringNo reportSplit or no voteNo report
MassMutualNo reportForNo report
Neuberger BermanNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Nuvation Bio Inc. meeting?

275 Form N-PX filers reported votes at the meeting of 21 May 2026. On say-on-pay, 26 of 262 voted against management (9.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Nuvation Bio Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Nuvation Bio Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Nuvation Bio Inc. with a meeting date within three days of 21 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.